DrugPatentWatch Database Preview
Anchen Pharms Company Profile
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-five approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Summary for Anchen Pharms
| US Patents: | 0 |
| Tradenames: | 21 |
| Ingredients: | 21 |
| NDAs: | 25 |
Drugs and US Patents for Anchen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anchen Pharms | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202206-003 | Feb 6, 2014 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Anchen Pharms | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202206-007 | Feb 6, 2014 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Anchen Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091360-002 | Oct 4, 2011 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Anchen Pharms | DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 078445-001 | Feb 26, 2009 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
